An open-label, multi-centre, phase Ib/II study of PI3K beta selective inhibitor GSK2636771 administered in combination with paclitaxel in patients with advanced gastric cancer having alterations in PI3K/Akt pathway

  • Jung, M.; 
  • Kim, C.; 
  • Kim, H.; 
  • Lee, C.; 
  • Lee, H.; 
  • ... Hwang, I.; 
  • 외 7명
Citations

WEB OF SCIENCE

6
제목
An open-label, multi-centre, phase Ib/II study of PI3K beta selective inhibitor GSK2636771 administered in combination with paclitaxel in patients with advanced gastric cancer having alterations in PI3K/Akt pathway
저자
Jung, M.; Kim, C.; Kim, H.; Lee, C.; Lee, H.; Bae, W.; Jeung, H.; Zang, D.; Park, S.; Hwang, I.; Kim, H.; Rha, S.; Chung, H.
DOI
10.1016/j.annonc.2021.05.034
발행일
2021-07
유형
Meeting Abstract
저널명
Annals of Oncology
권
32
페이지
S206 ~ S206